NCT04639752

Brief Summary

The project aims to test the clinical effectiveness of the Mom´s Supporting Moms intervention, a newly developed approach to the prevention of postpartum depression (PPD) and to determine its cost-effectiveness. The approach consists of online screening for risk of PPD in obstetric settings, and subsequent remote peer support intervention for women at risk of PPD development. As a preparation for proposed study, investigators have developed the Mom´s Supporting Moms intervention which is based in mother-to-mother delivered psychoeducation, basic procedures of cognitive behavioral therapy and mindfulness, shared personal experience with postpartum depression and, if necessary, referring to a professional consultation. Proposed study will allow investigators to bring missing Czech methodological procedures for the early screening of PPD development risk, and for subsequent non-pharmacological intervention. Further, investigators will be able to present economic data on proposed intervention to relevant stakeholders in mental health policy. To achieve these aims, investigators will 1) set up a screening program in five Czech maternity hospitals 2) conduct a randomized controlled trial (n= 60 per each arm), and 3) conduct a cost-effectiveness analysis of the Mom´s Supporting Moms intervention. Investigators will test the following primary hypotheses: H1: Mom´s Supporting Moms intervention will decrease depressive symptoms in women at risk of PPD development. Secondary hypotheses: SH1: Mom´s Supporting Moms intervention will reduce anxiety symptoms in women at risk of PPD development. SH2: Mom´s Supporting Moms intervention will increase women's health-related quality of life. SH3: Mom´s Supporting Moms intervention is cost-effective in comparison to treatment as usual.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 20, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

3 years

First QC Date

November 13, 2020

Last Update Submit

April 8, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postpartum depressive symptoms

    self-rated depressive symptomatology measured by Edinburgh Postnatal Depression Scale. Score range 0-30, higher score represents worse outcome.

    6 weeks postpartum

Secondary Outcomes (3)

  • Postpartum anxiety symptoms

    6 weeks postpartum

  • Postpartum health-related quality of life

    6 weeks postpartum

  • Cost-effectiveness

    6 weeks, 3 months, and year 1 postpartum

Other Outcomes (3)

  • Postpartum depressive symptoms

    3 months postpartum

  • Postpartum anxiety symptoms

    3 months postpartum

  • Postpartum health-related quality of life

    3 months postpartum

Study Arms (2)

Mom´s Supporting Mom (MSM)

EXPERIMENTAL

A preventive intervention that involves psychoeducation and peer techniques described in study detailed description.

Behavioral: Mom´s Supporting Mom

Enhanced Treatment as Usual

ACTIVE COMPARATOR

Referral to treatment in the community and monitoring

Behavioral: Enhanced Treatment As Usual

Interventions

A preventive peer consultation intervention for Postpartum Depression.

Also known as: MSM
Mom´s Supporting Mom (MSM)

Referral to treatment in the community, clinical monitoring

Also known as: ETAU
Enhanced Treatment as Usual

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • sex-female
  • childbirth in the hospital
  • signing of informed consent
  • email address ownership
  • age 18 - 45 years

You may not qualify if:

  • \- acute medical illness or significant pregnancy complication (based on self-report)
  • INTERVENTION PHASE
  • Edinburgh Postpartum Depression Scale score ≥10.
  • participant identified through the Screening Phase of the study
  • \- acute suicidal behavior (based on self-report)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Mental Health

Klecany, 25067, Czechia

RECRUITING

Related Publications (1)

  • Sebela A, Horakova A, Nemcova H, Kuklova M, Noskova E, Svancer P, Byatt N, Janovska A, Hrdlickova K. Mom Supporting Mom: Effective Peer Support Intervention for Women with Postpartum Psychological Distress. Psychosoc Interv. 2025 Jul 29;34(3):151-160. doi: 10.5093/pi2025a12. eCollection 2025 Sep.

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Antonin Sebela, Ph.D.

    National Institute of Mental Health, Klecany, Czechia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The person administering the outcome measures is blind to participant group.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Two groups: One receives MSM prevention intervention and the other group receives Enhanced Treatment as Usual (referral and monitoring).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 13, 2020

First Posted

November 20, 2020

Study Start

November 1, 2020

Primary Completion

October 31, 2023

Study Completion

April 30, 2024

Last Updated

April 11, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

De-identified data may be made available to other researchers.

Shared Documents
ICF
Time Frame
After the completion of the study
Access Criteria
Permission of the PI

Locations